Sarcopenia in Clinical Practice: Evidence-Based Strategies for Screening, Diagnosis, and Management
Includes a Live Web Event on 12/03/2026 at 12:00 PM (EST)
-
Register
- Non-Member - $25
- Comp Member - $15
- Emeritus Member - $15
- Regular Member - $15
- Retired Member - $15
- Spouse Member - $15
- GSA Staff - Free!
- Transitional Member - $15
- Graduate Student/Post-Doc Member - $15
- Undergraduate Student Member - $15
Since sarcopenia was formally classified as a disease in the 10th Edition of the International Classification of Diseases (ICD-10) in 2016, it has remained substantially underdiagnosed and under documented in clinical practice. Despite its strong association with falls, functional decline, disability, and reduced quality of life, many healthcare providers lack familiarity with current diagnostic criteria, screening tools, and evidence-based interventions. This workshop will address these critical gaps by providing practical, clinically relevant guidance on identifying and managing sarcopenia, with particular attention to emerging challenges such as sarcopenic obesity and the impact of GLP-1 receptor agonist therapies on muscle health.
Rosaly Correa de Araujo, MD, MSc, PhD
Senior Scientific Advisor
National Institute on Aging, National Institutes of Health
Dr. Correa is the Program Official overseeing the scientific and business operations of the AgingResearchBiobank, including maintaining and distributing de-identified biospecimens and associated phenotypic, clinical, and imaging data from numerous NIA-funded longitudinal studies and clinical trials on aging to the broader scientific community worldwide. She also oversees the ongoing research portfolio generated by the numerous research applications granted access to the biobank’s resources. In addition to her expertise in biobanking, data science, and related regulatory and bioethical issues, her other areas of scientific interest include policy development; chronic conditions/multimorbidity and medication management in older adults, with particular emphasis on older women; ethnogeriatrics; global health and health diplomacy; and the impact of culture, religion, and spirituality in health. A specific research interest and contribution is age-related loss of muscle mass (“sarcopenia”), strength, and function.
Roger Fielding, PhD
Senior Scientist and Professor
Tufts University
Roger A. Fielding, PhD, is a Senior Scientist with the Metabolism and Basic Biology of Aging Directive at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. He is also Professor of Nutrition at the Friedman School of Nutrition Science and Policy, Professor of Medicine at Tufts University School of Medicine, and the Associate Director of the Boston Claude D. Pepper Older Americans Independence Center. Dr. Fielding is an internationally known researcher. He has published over 300 peer-reviewed papers(H-index 117). He has a strong record of extramural funding, including support from the NIH, USDA, foundations, and industry. In 2015, he received the Olof Johnell Science Award from the International Osteoporosis Foundation, and in 2021 he received the Herbert Fleisch Medal from the same organization. In 2024, he received the Excellence in Rehabilitation of Aging Persons Award from the Gerontological Society of America.
Stuart Phillips, PhD, RD, FCAHS
Professor and Canada Research Chair
McMaster University, Department of Kinesiology
Dr. Stuart Phillips is a Distinguished University Professor in the Department of Kinesiology and a member of the School of Medicine at McMaster University. He is a Tier 1 Canada Research Chair in Skeletal Muscle Health. Dr. Phillips' work centers on the interaction of exercise/physical activity, aging, and nutrition in skeletal muscle and body composition. Dr. Phillips is a fellow of the Canadian Academy of Health Sciences (FCAHS), the American College of Sports Medicine (FACSM), the Canadian Society for Exercise Physiology (FCSEP) and the Royal Society of Canada (FRSC).

Carla Prado, PhD, RD, FCAHS
University of Alberta
All times are ET
Agenda
| 12:00 PM | Introduction & Overview |
| 12:05 PM | Definitions, Diagnostic Criteria, and Common Misconceptions |
| 12:15 PM | Screening and Diagnosis: Practical Demonstration |
| 12:35 PM | Evidence-Based Nutrition and Lifestyle Interventions |
| 12:55 PM | Pharmacological Interventions: Emerging Therapies |
| 1:00 PM | Sarcopenic Obesity and Emerging Clinical Considerations |
| 1:10 PM | Clinical Practice Implications and Research Needs |
| 1:30 PM | Workshop Concludes |